Breast cancer, estrogen receptor and ligands.
This review emphasizes the relationship of breast cancer, estrogen receptor and ligands, especially the centrality of the estrogen receptor, which mediates on one hand the hormone-induced gene transcription and on the other hand the anti-estrogen action against breast cancer. The characterization of the estrogen receptor ligand-binding domain co-crystallized with agonists or antagonists provided a molecular basis to gain an insight into the regulation of estrogen receptor and, thereby, to describe the mechanism of the hormone therapy in treating breast cancer.
Bai
Zhenlin
Z
Institute of Pharmacy, Freie Universität Berlin, Knigin-Luise-Strasse 2 + 4, Berlin, Germany.
Gust
Ronald
R
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000209:etiology; D004965:Estrogen Antagonists; D005260:Female; D006801:Humans; D008024:Ligands; D011960:Receptors, Estrogen / Q000737:chemistry / Q000187:drug effects* / Q000235:genetics; D020845:Selective Estrogen Receptor Modulators; D014158:Transcription, Genetic
D004965:Estrogen Antagonists; D008024:Ligands; D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators